New diabetes clinical trial: Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs

Published on: December 25, 2025 at 11:00PM
Conditions: Heart Failure; Diabete Type 2; Arterial Hypertension
Interventions: Drug: Tirzepatide (Mounjaro); Drug: dapagliflozin, empagliflozin, metformin
Sponsors: Nazarbayev University
Active, not recruiting
https://ift.tt/wuON5pa